Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her non-profit TTAM for $305 million, surpassing a prior winning bid from Regeneron. The deal, which excludes the company’s liabilities, may ease public concerns over genetic data transfers, given Wojcicki’s continued leadership. He elaborates on past controversies surrounding 23andMe, including legal issues that previously barred Wojcicki from bidding on her company. Cochrane highlights that Wojcicki is backed by a Fortune 500 firm, which enhances confidence about the future of 23andMe. Following the main story, Cochrane welcomes listeners to episode 1827 and gives shoutouts to his sponsor, GoDaddy.